IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer
Stabile, L.P, Egloff, A.M, Gibson, M.K, Gooding, W.E, Ohr, J, Zhou, P, Rothenberger, N.J, Wang, L, Geiger, J.L, Flaherty, J.T, Grandis, J.R, Bauman, J.E
Published in Oral oncology (01.06.2017)
Published in Oral oncology (01.06.2017)
Get full text
Journal Article
Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck
Argiris, A., Kotsakis, A.P., Hoang, T., Worden, F.P., Savvides, P., Gibson, M.K., Gyanchandani, R., Blumenschein, G.R., Chen, H.X., Grandis, J.R., Harari, P.M., Kies, M.S., Kim, S.
Published in Annals of oncology (01.01.2013)
Published in Annals of oncology (01.01.2013)
Get full text
Journal Article
Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer
Peyser, N D, Freilino, M, Wang, L, Zeng, Y, Li, H, Johnson, D E, Grandis, J R
Published in Oncogene (03.03.2016)
Published in Oncogene (03.03.2016)
Get full text
Journal Article
Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck cancer
Argiris, A., Bauman, J.E., Ohr, J., Gooding, W.E., Heron, D.E., Duvvuri, U., Kubicek, G.J., Posluszny, D.M., Vassilakopoulou, M., Kim, S., Grandis, J.R., Johnson, J.T., Gibson, M.K., Clump, D.A., Flaherty, J.T., Chiosea, S.I., Branstetter, B., Ferris, R.L.
Published in Annals of oncology (01.08.2016)
Published in Annals of oncology (01.08.2016)
Get full text
Journal Article
Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation
WHEELER, S. E, SUZUKI, S, GRANDIS, J. R, THOMAS, S. M, SEN, M, LEEMAN-NEILL, R. J, CHIOSEA, S. I, KUAN, C.-T, BIGNER, D. D, GOODING, W. E, LAI, S. Y
Published in Oncogene (16.09.2010)
Published in Oncogene (16.09.2010)
Get full text
Journal Article
Lyn Kinase Mediates Cell Motility and Tumor Growth in EGFRvIII-Expressing Head and Neck Cancer
WHEELER, Sarah E, MORARIU, Elena M, BEDNASH, Joseph S, OTTE, Charlton G, SEETHALA, Raja R, CHIOSEA, Simion I, GRANDS, Jennifer R
Published in Clinical cancer research (15.05.2012)
Published in Clinical cancer research (15.05.2012)
Get full text
Journal Article
PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells
SUN, Q, MING, L, THOMAS, S. M, WANG, Y, CHEN, Z. G, FERRIS, R. L, GRANDIS, J. R, ZHANG, L, YU, J
Published in Oncogene (18.06.2009)
Published in Oncogene (18.06.2009)
Get full text
Journal Article
Response assessment by combined PET–CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy
Passero, V.A., Branstetter, B.F., Shuai, Y., Heron, D.E., Gibson, M.K., Lai, S.Y., Kim, S.W., Grandis, J.R., Ferris, R.L., Johnson, J.T., Argiris, A.
Published in Annals of oncology (01.11.2010)
Published in Annals of oncology (01.11.2010)
Get full text
Journal Article
Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer
Argiris, A., Karamouzis, M.V., Smith, R., Kotsakis, A., Gibson, M.K., Lai, S.Y., Kim, S., Branstetter, B.F., Shuai, Y., Romkes, M., Wang, L., Grandis, J.R., Ferris, R.L., Johnson, J.T., Heron, D.E.
Published in Annals of oncology (01.11.2011)
Published in Annals of oncology (01.11.2011)
Get full text
Journal Article
Gefitinib potentiates myeloid cell differentiation by ATRA
Miranda, M B, Duan, R, Thomas, S M, Grandis, J R, Redner, R L, Jones, J E, Johnson, D E
Published in Leukemia (01.08.2008)
Published in Leukemia (01.08.2008)
Get full text
Journal Article